Electronic Delivery of Documents. Participant authorizes the Company to deliver electronically any prospectuses or other documentation related to the Option and any other compensation or benefit plan or arrangement in effect from time to time (including, without limitation, reports, proxy statements or other documents that are required to be delivered to participants in such arrangements pursuant to federal or state laws, rules or regulations). For this purpose, electronic delivery will include, without limitation, delivery by m
...eans of e-mail or e-mail notification that such documentation is available on the Company’s Intranet site. Upon written request, the Company will provide to Participant a paper copy of any document also delivered to Participant electronically. The authorization described in this paragraph may be revoked by Participant at any time by written notice to the Company. 3 EX-10.14 18 tm2113659d7_ex10-14.htm EXHIBIT 10.14 Exhibit 10.14 COGNITION THERAPEUTICS, INC. 2021 EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE AND AWARD AGREEMENT Cognition Therapeutics, Inc., a Delaware corporation (the “Company”), pursuant to its 2021 Equity Incentive Plan (the “Plan”), hereby grants to the individual listed below (“Participant”) an option to purchase the number of Shares set forth below (the “Option”). The Option described in this Stock Option Grant Notice (the “Grant Notice”) is subject to the terms and conditions set forth in the Award Agreement attached hereto as Exhibit A (the “Agreement”) and the Plan, each of which is incorporated herein by reference. Unless otherwise defined herein, capitalized terms used in this Grant Notice and the Agreement will have the meanings defined in the Plan. Participant: [_________] Grant Date: [_________] Exercise Price Per Share: [_________] Total Number of Shares Subject to Option: [_________] Expiration Date: [_________] Type of Option: ̈ Incentive Stock Option (to the extent permitted by 422(d) of the Code) ̈ Non-Qualified Stock Option Vesting Schedule: [_________] By signing below, Participant agrees to be bound by the terms and conditions of the Plan, the Agreement and this Grant Notice. This document may be executed, including by electronic means, in multiple counterparts, each of which will be deemed an original, and all of which together will be deemed a single instrument. COGNITION THERAPEUTICS, INC. participant Name: Name: Title: EXHIBIT A TO STOCK OPTION GRANT NOTICE AWARD AGREEMENT 1. Award of Option. Effective as of the Grant Date set forth in the Grant Notice, the Company has granted to Participant the Option to purchase part or all of the aggregate number of Shares set forth in the Grant Notice, subject to the terms and conditions set forth in the Grant Notice, the Plan and this Agreement.
View More
Electronic Delivery of Documents. Participant authorizes the Company to deliver electronically any prospectuses or other documentation related to the Option and any other compensation or benefit plan or arrangement in effect from time to time (including, without limitation, reports, proxy statements or other documents that are required to be delivered to participants in such arrangements pursuant to federal or state laws, rules or regulations). For this purpose, electronic delivery will include, without limitation, delivery by m
...eans of e-mail or e-mail notification that such documentation is available on the Company’s Intranet site. Upon written request, the Company will provide to Participant a paper copy of any document also delivered to Participant electronically. The authorization described in this paragraph may be revoked by Participant at any time by written notice to the Company. 3 EX-10.14 18 tm2113659d7_ex10-14.htm 2 EX-10.13 17 tm2113659d7_ex10-13.htm EXHIBIT 10.14 10.13 Exhibit 10.14 10.13 COGNITION THERAPEUTICS, INC. 2021 EQUITY INCENTIVE PLAN RESTRICTED STOCK OPTION UNIT GRANT NOTICE AND AWARD AGREEMENT Cognition Therapeutics, Inc., a Delaware corporation (the “Company”), pursuant to its 2021 Equity Incentive Plan (the “Plan”), hereby grants to the individual listed below (“Participant”) an option to purchase the number of Shares restricted stock units set forth below (the “Option”). “Restricted Stock Units”). The Option Restricted Stock Units described in this Restricted Stock Option Unit Grant Notice (the “Grant Notice”) is are subject to the terms and conditions set forth in the Award Agreement attached hereto as Exhibit A (the “Agreement”) and the Plan, each of which is incorporated herein by reference. Unless otherwise defined herein, capitalized terms used in this Grant Notice and the Agreement will have the meanings defined in the Plan. Participant: [_________] Grant Date: [_________] Exercise Price Per Share: [_________] Total Number of Shares Subject to Option: Restricted Stock Units: [_________] Expiration Date: [_________] Type of Option: ̈ Incentive Stock Option (to the extent permitted by 422(d) of the Code) ̈ Non-Qualified Stock Option Vesting Schedule: [_________] By signing below, Participant agrees to be bound by the terms and conditions of the Plan, the Agreement and this Grant Notice. This document may be executed, including by electronic means, in multiple counterparts, each of which will be deemed an original, and all of which together will be deemed a single instrument. COGNITION THERAPEUTICS, INC. participant Name: Name: Title: EXHIBIT A TO RESTRICTED STOCK OPTION Unit GRANT NOTICE AWARD AGREEMENT 1. Award of Option. Restricted Stock Units. Effective as of the Grant Date set forth in the Grant Notice, the Company has granted to Participant the Option to purchase part or all of the aggregate number of Shares Restricted Stock Units set forth in the Grant Notice, subject to the restrictions and on the terms and conditions set forth in the Grant Notice, the Plan and this Agreement. Each Restricted Stock Unit represents the right to receive one Share at the times and subject to the conditions set forth herein.
View More
Electronic Delivery of Documents. Participant authorizes the Company to deliver electronically any prospectuses or other documentation related to the Option and any other compensation or benefit plan or arrangement in effect from time to time (including, without limitation, reports, proxy statements or other documents that are required to be delivered to participants in such arrangements pursuant to federal or state laws, rules or regulations). For this purpose, electronic delivery will include, without limitation, delivery by m
...eans of e-mail or e-mail notification that such documentation is available on the Company’s Intranet site. Upon written request, the Company will provide to Participant a paper copy of any document also delivered to Participant electronically. The authorization described in this paragraph may be revoked by Participant at any time by written notice to the Company. 3 EX-10.14 18 tm2113659d7_ex10-14.htm 17 tm218551d7_ex10-14.htm EXHIBIT 10.14 Exhibit 10.14 COGNITION CENTURY THERAPEUTICS, INC. 2021 EQUITY INCENTIVE PLAN RESTRICTED STOCK OPTION UNIT GRANT NOTICE AND AWARD AGREEMENT Cognition Century Therapeutics, Inc., a Delaware corporation (the “Company”), pursuant to its 2021 Equity Incentive Plan (the “Plan”), hereby grants to the individual listed below (“Participant”) an option to purchase the number of Shares restricted stock units set forth below (the “Option”). “Restricted Stock Units”). The Option Restricted Stock Units described in this Restricted Stock Option Unit Grant Notice (the “Grant Notice”) is are subject to the terms and conditions set forth in the Award Agreement attached hereto as Exhibit A (the “Agreement”) and the Plan, each of which is incorporated herein by reference. Unless otherwise defined herein, capitalized terms used in this Grant Notice and the Agreement will have the meanings defined in the Plan. Participant: [_________] Grant Date: [_________] Exercise Price Per Share: [_________] Total Number of Shares Subject to Option: Restricted Stock Units: [_________] Expiration Date: [_________] Type of Option: ̈ Incentive Stock Option (to the extent permitted by 422(d) of the Code) ̈ Non-Qualified Stock Option Vesting Schedule: [_________] By signing below, Participant agrees to be bound by the terms and conditions of the Plan, the Agreement and this Grant Notice. This document may be executed, including by electronic means, in multiple counterparts, each of which will be deemed an original, and all of which together will be deemed a single instrument. COGNITION CENTURY THERAPEUTICS, INC. participant Name: Name: Title: EXHIBIT A TO RESTRICTED STOCK OPTION Unit GRANT NOTICE AWARD AGREEMENT 1. Award of Option. Restricted Stock Units. Effective as of the Grant Date set forth in the Grant Notice, the Company has granted to Participant the Option to purchase part or all of the aggregate number of Shares Restricted Stock Units set forth in the Grant Notice, subject to the restrictions and on the terms and conditions set forth in the Grant Notice, the Plan and this Agreement. Each Restricted Stock Unit represents the right to receive one Share at the times and subject to the conditions set forth herein.
View More
Electronic Delivery of Documents. Participant authorizes the Company to deliver electronically any prospectuses or other documentation related to the Option and any other compensation or benefit plan or arrangement in effect from time to time (including, without limitation, reports, proxy statements or other documents that are required to be delivered to participants in such arrangements pursuant to federal or state laws, rules or regulations). For this purpose, electronic delivery will include, without limitation, delivery by m
...eans of e-mail or e-mail notification that such documentation is available on the Company’s Intranet site. Upon written request, the Company will provide to Participant a paper copy of any document also delivered to Participant electronically. The authorization described in this paragraph may be revoked by Participant at any time by written notice to the Company. 3 EX-10.14 18 tm2113659d7_ex10-14.htm EX-10.22 10 tm2113659d10_ex10-22.htm EXHIBIT 10.14 10.22 Exhibit 10.14 10.22 COGNITION THERAPEUTICS, INC. 2021 EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE AND AWARD AGREEMENT Cognition Therapeutics, Inc., a Delaware corporation (the “Company”), pursuant to its 2021 Equity Incentive Plan (the “Plan”), hereby grants to the individual listed below (“Participant”) an option to purchase the number of Shares set forth below (the “Option”). The Option described in this Stock Option Grant Notice (the “Grant Notice”) is subject to the terms and conditions set forth in the Award Agreement attached hereto as Exhibit A (the “Agreement”) and the Plan, each of which is incorporated herein by reference. Unless otherwise defined herein, capitalized terms used in this Grant Notice and the Agreement will have the meanings defined in the Plan. Participant: [_________] Grant Date: [_________] Exercise Price Per Share: [_________] Total Number of Shares Subject to Option: [_________] Expiration Date: [_________] Type of Option: ̈ Incentive Stock Option (to the extent permitted by 422(d) of the Code) ̈ Non-Qualified Stock Option Vesting Schedule: [_________] By signing below, Participant agrees to be bound by the terms and conditions of the Plan, the Agreement and this Grant Notice. This document may be executed, including by electronic means, in multiple counterparts, each of which will be deemed an original, and all of which together will be deemed a single instrument. COGNITION THERAPEUTICS, INC. participant Name: Name: Title: EXHIBIT A TO STOCK OPTION GRANT NOTICE AWARD AGREEMENT 1. Award of Option. Effective as of the Grant Date set forth in the Grant Notice, the Company has granted to Participant the Option to purchase part or all of the aggregate number of Shares set forth in the Grant Notice, subject to the terms and conditions set forth in the Grant Notice, the Plan and this Agreement.
View More
Electronic Delivery of Documents. Participant authorizes the Company to deliver electronically any prospectuses or other documentation related to the Option and any other compensation or benefit plan or arrangement in effect from time to time (including, without limitation, reports, proxy statements or other documents that are required to be delivered to participants in such arrangements pursuant to federal or state laws, rules or regulations). For this purpose, electronic delivery will include, without limitation, delivery by m
...eans of e-mail or e-mail notification that such documentation is available on the Company’s Intranet site. Upon written request, the Company will provide to Participant a paper copy of any document also delivered to Participant electronically. The authorization described in this paragraph may be revoked by Participant at any time by written notice to the Company. 4 EX-10.5 3 EX-10.14 18 tm2113659d7_ex10-14.htm EXHIBIT 10.14 fs12022a1ex10-5_lucyscient.htm FORM OF OPTION AWARD UNDER THE 2021 EQUITY INCENTIVE PLAN Exhibit 10.14 COGNITION THERAPEUTICS, 10.5 LUCY SCIENTIFIC DISCOVERY INC. 2021 EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE AND AWARD AGREEMENT Cognition Therapeutics, Inc., a Delaware corporation Lucy Scientific Discovery Inc. (the “Company”), pursuant to its 2021 Equity Incentive Plan (the “Plan”), hereby grants to the individual listed below (“Participant”) an option to purchase the number of Shares set forth below (the “Option”). The Option described in this Stock Option Grant Notice (the “Grant Notice”) is subject to the terms and conditions set forth in the Award Agreement attached hereto as Exhibit A (the “Agreement”) and the Plan, each of which is incorporated herein by reference. Unless otherwise defined herein, capitalized terms used in this Grant Notice and the Agreement will have the meanings defined in the Plan. Participant: [_________] Grant Date: [_________] Exercise Price Per Share: [_________] Total Number of Shares Subject to Option: [_________] Expiration Date: [_________] Type of Option: ̈ ☐ Incentive Stock Option (to the extent permitted by 422(d) of the Code) ̈ ☐ Non-Qualified Stock Option Vesting Schedule: [_________] By signing below, Participant agrees to be bound by the terms and conditions of the Plan, the Agreement and this Grant Notice. This document may be executed, including by electronic means, in multiple counterparts, each of which will be deemed an original, and all of which together will be deemed a single instrument. COGNITION THERAPEUTICS, LUCY SCIENTIFIC DISCOVERY INC. participant Name: Name: [_________] Title: EXHIBIT A TO STOCK OPTION GRANT NOTICE AWARD AGREEMENT 1. Award of Option. Effective as of the Grant Date set forth in the Grant Notice, the Company has granted to Participant the Option to purchase part or all of the aggregate number of Shares set forth in the Grant Notice, subject to the terms and conditions set forth in the Grant Notice, the Plan and this Agreement.
View More
Electronic Delivery of Documents. Participant authorizes the Company to deliver electronically any prospectuses or other documentation related to the Option and any other compensation or benefit plan or arrangement in effect from time to time (including, without limitation, reports, proxy statements or other documents that are required to be delivered to participants in such arrangements pursuant to federal or state laws, rules or regulations). For this purpose, electronic delivery will include, without limitation, delivery by m
...eans of e-mail or e-mail notification that such documentation is available on the Company’s Intranet site. Upon written request, the Company will provide to Participant a paper copy of any document also delivered to Participant electronically. The authorization described in this paragraph may be revoked by Participant at any time by written notice to the Company. 3 EX-10.14 18 tm2113659d7_ex10-14.htm EX-10.13 16 tm218551d7_ex10-13.htm EXHIBIT 10.14 10.13 Exhibit 10.14 COGNITION 10.13 CENTURY THERAPEUTICS, INC. 2021 EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE AND AWARD AGREEMENT Cognition Century Therapeutics, Inc., a Delaware corporation (the “Company”), pursuant to its 2021 Equity Incentive Plan (the “Plan”), hereby grants to the individual listed below (“Participant”) an option to purchase the number of Shares set forth below (the “Option”). The Option described in this Stock Option Grant Notice (the “Grant Notice”) is subject to the terms and conditions set forth in the Award Agreement attached hereto as Exhibit A (the “Agreement”) and the Plan, each of which is incorporated herein by reference. Unless otherwise defined herein, capitalized terms used in this Grant Notice and the Agreement will have the meanings defined in the Plan. Participant: [_________] Grant Date: [_________] Exercise Price Per Share: [_________] Total Number of Shares Subject to Option: [_________] Expiration Date: [_________] Type of Option: ̈ Incentive Stock Option (to the extent permitted by 422(d) of the Code) ̈ Non-Qualified Stock Option Vesting Schedule: [_________] By signing below, Participant agrees to be bound by the terms and conditions of the Plan, the Agreement and this Grant Notice. This document may be executed, including by electronic means, in multiple counterparts, each of which will be deemed an original, and all of which together will be deemed a single instrument. COGNITION CENTURY THERAPEUTICS, INC. participant Name: Name: Title: EXHIBIT A TO STOCK OPTION GRANT NOTICE AWARD AGREEMENT 1. Award of Option. Effective as of the Grant Date set forth in the Grant Notice, the Company has granted to Participant the Option to purchase part or all of the aggregate number of Shares set forth in the Grant Notice, subject to the terms and conditions set forth in the Grant Notice, the Plan and this Agreement.
View More
Electronic Delivery of Documents. Participant authorizes the Company to deliver electronically any prospectuses or other documentation related to the Option and any other compensation or benefit plan or arrangement in effect from time to time (including, without limitation, reports, proxy statements or other documents that are required to be delivered to participants in such arrangements pursuant to federal or state laws, rules or regulations). For this purpose, electronic delivery will include, without limitation, delivery by m
...eans of e-mail or e-mail notification that such documentation is available on the Company’s Intranet site. Upon written request, the Company will provide to Participant a paper copy of any document also delivered to Participant electronically. The authorization described in this paragraph may be revoked by Participant at any time by written notice to the Company. 3 EX-10.14 18 tm2113659d7_ex10-14.htm EXHIBIT 10.14 A-3 EX-10.3 4 d305238dex103.htm EX-10.3 EX-10.3 Exhibit 10.14 COGNITION 10.3 INHIBIKASE THERAPEUTICS, INC. 2021 2020 EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE AND AWARD AGREEMENT Cognition Inhibikase Therapeutics, Inc., a Delaware corporation (the “Company”), pursuant to its 2021 2020 Equity Incentive Plan (the “Plan”), hereby grants to the individual listed below (“Participant”) an option to purchase the number of Shares set forth below (the “Option”). The Option described in this Stock Option Grant Notice (the “Grant Notice”) is subject to the terms and conditions set forth in the Award Agreement attached hereto as Exhibit A (the “Agreement”) and the Plan, each of which is incorporated herein by reference. Unless otherwise defined herein, capitalized terms used in this Grant Notice and the Agreement will have the meanings defined in the Plan. Participant: [_________] Grant Date: [_________] Exercise Price Per Share: [_________] Total Number of Shares Subject to Option: [_________] Expiration Date: [_________] Type of Option: ̈ ☐ Incentive Stock Option (to the extent permitted by 422(d) of the Code) ̈ ☐ Non-Qualified Stock Option Vesting Schedule: [_________] 1. [_]% of grant contingent upon completion of [_] study and release of results: a) Fully vested if study completed and reported by [_] or earlier b) [_]% vested if study completed and reported by [_] c) [_]% vested if study completed and reported by [_] d) Forfeited in its entirety if study not completed and reported by [_] 2. [_]% of grant contingent upon engagement with and FDA agreement with [_] protocol design: a) Fully vested if FDA agreement by end of [_] b) [_]% vested if FDA agreement by end of [_] c) [_]% vested if FDA agreement by end of [_] d) Forfeited in its entirety if FDA agreement not received by [_] By signing below, Participant agrees to be bound by the terms and conditions of the Plan, the Agreement and this Grant Notice. This document may be executed, including by electronic means, in multiple counterparts, each of which will be deemed an original, and all of which together will be deemed a single instrument. COGNITION INHIBIKASE THERAPEUTICS, INC. participant PARTICIPANT Name: Name: Title: A-2 EXHIBIT A TO STOCK OPTION GRANT NOTICE AWARD AGREEMENT 1. Award of Option. Effective as of the Grant Date set forth in the Grant Notice, the Company has granted to Participant the Option to purchase part or all of the aggregate number of Shares set forth in the Grant Notice, subject to the terms and conditions set forth in the Grant Notice, the Plan and this Agreement.
View More
